Curewell Capital has acquired Wilmington PharmaTech (WPT), according to a news release.
WPT, founded in 2003 and based in Newark, Delaware, is a contract research, development and manufacturing organization focused on custom small molecule API development and manufacturing.
Curewell, founded in 2021 and based in Los Angeles, is a middle market private